AIxCrypto Holdings, Inc. (NasdaqCM: AIXC)
Health Care · Biotechnology · US
$0.93
-16.81% today · -39.8% 1Y
AIxCrypto Holdings, Inc. (NasdaqCM: AIXC) operates in the Biotechnology industry within the Health Care sector. The company is valued at $22.66M and employs 10 people.
Over the last twelve months the share price has lost 39.8%, trading between 0.59 and 8.81.
Tweenvest scores AIxCrypto Holdings, Inc. across four factors: quality 26/100. Its strongest factor is quality.
AIXC price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $22.66M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -2.95
- Dividend yield
- —
- Beta (5Y)
- 0.53
- 52-week high
- $8.81
- 52-week low
- $0.59
- Avg volume (3M)
- —
- Shares outstanding
- 20.23M
- Employees
- 10
- Next earnings
- —
About AIxCrypto Holdings, Inc.
AIxCrypto Holdings, Inc. is a clinical-stage biopharmaceutical company committed to discovering and developing innovative treatments for both adult and pediatric oncology. Its leading investigational therapeutic, QN-302, is a small molecule G-quadruplexes (G4)-selective transcription inhibitor currently progressing through Phase I clinical trials for pancreatic cancer and a range of other solid tumors. The firm is also advancing Pan-RAS, a preclinical-stage program targeting advanced solid tumors. Founded in 1996 and headquartered in Carlsbad, California, the company rebranded from Qualigen Therapeutics, Inc. to AIxCrypto Holdings, Inc. in November 2025.
- ISIN
- US74754R3012
- Founded
- 1996
- Listed since
- Jun 23, 2015
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $469.68B | $265.79 | +0.48% |
| Amgen Inc.NasdaqGS: AMGN | $239.09B | $442.24 | -0.36% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $184.47B | $148.77 | +1.38% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $140.13B | $552.85 | +0.96% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.24B | $833.56 | +0.61% |
| argenx SEENXTBR: ARGX | $64.17B | €879.20 | +1.74% |
| CSL LimitedASX: CSL | $59.49B | AU$173.64 | +2.68% |
| Moderna, Inc.NasdaqGS: MRNA | $55.45B | $158.83 | +14.36% |
Figures last refreshed Aug 18, 2026.